Monitor the company's response to the USFDA and any subsequent regulatory action (e.g., warning letter, import alert) that could affect API supply or revenue from the Mexico facility. The two observations are not detailed, so the risk is currently low but warrants tracking for escalation.
Price Chart
Executive Summary
Dr. Reddy's disclosed that the USFDA completed a records assessment at its API manufacturing facility in Mexico (Jiutepec, Morelos) between July 17 and September 8, 2026, issuing a Form FDA 2953 with two observations. The company will respond within the stipulated timeline. This is a routine regulatory follow-up with no material financial impact disclosed, and the two observations are not quantified or characterized as critical.
Key Facts
- USFDA conducted a records assessment under Section 704(a)(4) at Dr. Reddy's API facility in Mexico (Industrias Químicas Falcón de México, S.A. de C.V.) from July 17 to September 8, 2026.
- The USFDA issued a Form FDA 2953 containing two observations; the company will respond within the stipulated timeline.
- No warning letter, shutdown, import alert, or material financial impact was disclosed in the filing.
Financial Impact
No financial figures disclosed; two observations from a records assessment with no indication of material cost or revenue impact.
Risk Factors
- Potential escalation to a warning letter or import alert if the USFDA deems the response inadequate, which could disrupt API production and sales.
- Uncertainty around the nature of the two observations — if they relate to data integrity or quality systems, remediation costs could be material.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000646 |
| Document: 0001575872-26-000646-index.html | 0001575872-26-000646 |
| Document: 0001575872-26-000646.txt | 0001575872-26-000646 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $11.91 $11.55 | ▼ −3.02% | ▼ −2.56% | $12.25 (+2.85%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Aug 26, 2026 5w ago | 6-K | $12.22 $12.16 | ▼ −0.49% | ▼ −1.15% | $12.25 (+0.25%) |
Aug 17, 2026 6w ago | 6-K | $12.11 $12.15 | ▲ +0.33% | ▲ +1.01% | $12.25 (+1.16%) |
Aug 13, 2026 7w ago | 6-K | $12.42 $12.27 | ▼ −1.21% | ▼ −1.01% | $12.25 (−1.37%) |
Aug 10, 2026 7w ago | 6-K | $12.15 $12.45 | ▲ +2.47% | ▲ +2.79% | $12.25 (+0.82%) |
Aug 3, 2026 8w ago | 6-K | $12.07 $12.10 | ▲ +0.25% | ▼ −1.55% | $12.25 (+1.49%) |
Jul 29, 2026 9w ago | 6-K | $11.76 $11.83 | ▲ +0.60% | ▼ −1.08% | $12.25 (+4.17%) |
Jul 23, 2026 10w ago | 6-K | $11.80 $11.79 | ▼ −0.08% | ▼ −0.19% | $12.25 (+3.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access